VANCOUVER, BC and MESA, AZ, Jan. 9,
2014 /PRNewswire/ - Avidus Management Group Inc. ("Avidus"
or the "Company") (TSX-V: AVD, OTC: ASNHF), announces that its
wholly owned subsidiary, Asantae, has published a White Paper on
IS2™, its revolutionary inflammation and immune support functional
beverage. The paper, by Dwight
Lundell, M.D., is titled, The Science of Inflammation
& Immunity.
IS2™ is a proprietary blend of unique ingredients synergistically
combined to support a proper immune and inflammatory response.
The White Paper details how 60 percent of the deaths worldwide
today are from non-communicable diseases (e.g. heart disease,
stroke, obesity, diabetes) and that the common pathology in all
these diseases, as well as in less dramatic conditions that plague
humankind (e.g. chronic pain, fibromyalgia, osteoarthritis), is
inflammation. The document also explores how the ingredients
found in IS2™ are shown to aid in resolving inflammation by
strengthening the body's natural immune system and inflammatory
processes.
- The IS2™ White Paper can be accessed at:
http://www.asantae.com/documents/the_science_of_is2.pdf
- A brief video presentation about IS2™ and inflammation can be
viewed at: http://vimeo.com/76877186
Launched in October 2013, IS2™ is
generating positive feedback from Asantae's customers and
distributors and has enabled the company to attract top network
marketers from other well-established companies.
About Avidus
Avidus Management Group Inc. (TSX-V: AVD, OTC: ASNHF), through its
wholly owned subsidiary, Asantae (www.asantae.com), develops,
produces and markets innovative nutritional products through direct
and network marketing channels. The ingredients in Asantae's
products have been shown to reduce chronic low-grade inflammation
and oxidative stress, and support a healthy immune system that,
according to scientific and medical research, are the underlying
conditions for most modern epidemic diseases (diabetes, heart
disease, obesity, stroke, etc.).
This news release may contain forward-looking statements relating
to the Company's operations or to the environment in which it
operates. Such statements are based on operations, estimates,
forecasts and projections. They are not guarantees of future
performance and involve risks and uncertainties that are difficult
to predict and may be beyond the Company's control. A number of
important factors could cause actual outcomes and results to differ
materially from those expressed in forward-looking statements,
including those set forth in the Company's regulatory filings. In
addition, such statements relate to the date on which they are made
and the Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, save and except as may be
required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Avidus Management Group Inc.
